Westfield Capital Management
MLAB icon

Westfield Capital Management’s Mesa Laboratories MLAB Stock Holding History

Westfield Capital Management’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,600
Closed -$239K – 260
2017
Q3 		$239K Buy
+1,600
New +$226K ﹤0.01% 248

Other funds holding MLAB

CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Westfield Capital Management's MLAB Position: Q4 2017 in Review

Westfield Capital Management sold out of Mesa Laboratories (MLAB) in Q4 2017, closing a stake of 1,600 shares — an estimated $239K sold.

Westfield Capital Management first reported a position in MLAB in Q3 2017 and held it in 1 quarter. The position peaked at $239K in Q3 2017. 93 funds tracked by Wall St. Rank hold MLAB as of Q4 2017.

  • Westfield Capital Management reported no remaining Mesa Laboratories position as of Q4 2017 after selling out during the quarter.
  • Westfield Capital Management sold 1,600 Mesa Laboratories shares in Q4 2017, an estimated $239K.
  • Westfield Capital Management first reported a position in Mesa Laboratories in Q3 2017 and held it in 1 quarter.
  • Westfield Capital Management's Mesa Laboratories position peaked at $239K in Q3 2017.
  • 93 funds tracked by Wall St. Rank held Mesa Laboratories as of Q4 2017.

Based on Westfield Capital Management's 13F filing for Q4 2017, filed 13 Feb 2018.